CompletedNot applicableNCT02201134

SEVOflurane Inhalation in CARdiac Arrest Resuscitated Patients Treated With Therapeutic Hypothermia

Studying PAPA syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Clermont-Ferrand
Principal Investigator
Sébastien PERBET
University Hospital, Clermont-Ferrand
Intervention
sevoflurane(drug)
Enrollment
20 target
Eligibility
18-75 years · All sexes
Timeline
2014 – 2017

Study locations (1)

Collaborators

University Hospital, Estaing · Hopital Gabriel Montpied

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02201134 on ClinicalTrials.gov

Other trials for PAPA syndrome

Additional recruiting or active studies for the same condition.

See all trials for PAPA syndrome →

← Back to all trials